BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10421271)

  • 41. Intermittent-low dose G-CSF treatment in a patient with chronic neutropenia.
    Yetgin S; Ozbek N
    Turk J Pediatr; 1998; 40(3):421-4. PubMed ID: 9763907
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [G-CSF (Neupogen Roche) in the treatment of patients with chronic aplastic anemia with severe neutropenia].
    Novotný J; Zvarová M; Prazáková L; Jandlová M; Konvicková L
    Vnitr Lek; 1995 Oct; 41(10):692-5. PubMed ID: 8578701
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Place of CSF in pediatric oncology].
    Hartmann O; Valteau-Couanet D
    Pathol Biol (Paris); 1993 Jan; 41(1):52. PubMed ID: 7686289
    [No Abstract]   [Full Text] [Related]  

  • 44. [Cyclic neutropenia and treatment with granulocyte colony-stimulating factor (G-CSF)].
    Anninga JK; Weening RS
    Ned Tijdschr Geneeskd; 1995 Feb; 139(8):394-7. PubMed ID: 7885503
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Successful treatment of cyclic neutropenia associated with hyperimmunoglobulin M syndrome using recombinant granulocyte-colony stimulating factor].
    Simon G; Maródi L
    Orv Hetil; 1995 Oct; 136(40):2169-72. PubMed ID: 7566951
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Therapeutic intensification: contribution of G-CSF].
    Marty M; Extra JM; Giacchetti S
    Pathol Biol (Paris); 1993 Jan; 41(1):53-5. PubMed ID: 7686290
    [No Abstract]   [Full Text] [Related]  

  • 47. [Colony stimulating factors in chemotherapy induced neutropenic fever].
    Sanz Rubiales A; García Alvarez G; Centeno Cortés C; Martín Ortega Y; Del Valle Rivero AL; Nieto Sanz J
    An Med Interna; 1998 Feb; 15(2):100-4. PubMed ID: 9542208
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Granulocyte colony-stimulating factor in toxic epidermal necrolysis (TEN) and Chelsea & Westminster TEN management protocol [corrected].
    de Sica-Chapman A; Williams G; Soni N; Bunker CB
    Br J Dermatol; 2010 Apr; 162(4):860-5. PubMed ID: 19912214
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclic neutropenia and severe hypogammaglobulinemia in a patient with excess of CD8-positive T lymphocytes: response to G-CSF therapy.
    Ferrero D; Pregno P; Omedè P; Dianzani U; Carbone A; di Celle PF; Gallo E
    Haematologica; 1993; 78(1):49-52. PubMed ID: 7684013
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Granulocyte colony-stimulating factor (G-CSF): a novel anticancer therapy based on the "universal dynamics of tumor growth"?
    Lopez-Lazaro M
    Exp Oncol; 2006 Sep; 28(3):249-51. PubMed ID: 17080023
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Usefulness of G-CSF in pediatric high risk cancer patients with fever and neutropenia].
    Rodríguez Z N; Tordecilla C J; Campbell B M; Joannon S P; Rizzardini L C; Soto A V; Verdugo L P
    Rev Chilena Infectol; 2005 Sep; 22(3):223-7. PubMed ID: 16077888
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endogenous haemopoietic growth factors in neutropenia and infection.
    Cebon J; Layton JE; Maher D; Morstyn G
    Br J Haematol; 1994 Feb; 86(2):265-74. PubMed ID: 7515265
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Use of G-CSF in chemotherapy of urogenital cancers].
    Droz JP; Théodore C
    Pathol Biol (Paris); 1993 Jan; 41(1):48-9. PubMed ID: 7686286
    [No Abstract]   [Full Text] [Related]  

  • 54. G-CSF: a very efficient therapy in chronic autoimmune neutropenia. A brief review of the literature.
    Bauduer F
    Hematol Cell Ther; 1998 Oct; 40(5):189-91. PubMed ID: 9844813
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Focus on granulocyte colony-stimulating factor-induced pulmonary toxicity].
    Noël-Savina E; Descourt R
    Bull Cancer; 2012 Feb; 99(2):211-7. PubMed ID: 22265942
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Present and future indications of G-CSF in breast cancer].
    Chevallier B
    Pathol Biol (Paris); 1993 Jan; 41(1):47. PubMed ID: 7686285
    [No Abstract]   [Full Text] [Related]  

  • 57. Osteoporosis in severe congenital neutropenia: inherent to the disease or a sequela of G-CSF treatment?
    Simon M; Lengfelder E; Reiter S; Hehlmann R
    Am J Hematol; 1996 Jun; 52(2):127. PubMed ID: 8638643
    [No Abstract]   [Full Text] [Related]  

  • 58. Recombinant methionyl human granulocyte colony-stimulating factor for the prevention and treatment of non-neutropenic infectious diseases.
    Daifuku R; Andresen J; Morstyn G
    J Antimicrob Chemother; 1993 Jul; 32 Suppl A():91-7. PubMed ID: 7691789
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytokines in human breast milk.
    Wallace JM; Ferguson SJ; Loane P; Kell M; Millar S; Gillmore WS
    Br J Biomed Sci; 1997 Jun; 54(2):85-7. PubMed ID: 9231454
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A phase II clinical trial of human urinary CSF (P-100) in pediatric patients].
    Tsuchida M; Ohara A; Tsukimoto I; Hanawa Y; Akatsuka J; Hoshi Y; Ueda Y; Yamamoto M; Akabane T; Komiyama J
    Rinsho Ketsueki; 1988 Jul; 29(7):1041-9. PubMed ID: 2460650
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.